Pimicotinib

CAS No. 2253123-16-7

Pimicotinib( —— )

Catalog No. M37228 CAS No. 2253123-16-7

Pimicotinib (ABSK021) is a potent CSF1R inhibitor with antitumor activity and can be used to study advanced solid tumors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 90 Get Quote
5MG 136 Get Quote
10MG 208 Get Quote
25MG 365 Get Quote
50MG 605 Get Quote
100MG 945 Get Quote
500MG 1890 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pimicotinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Pimicotinib (ABSK021) is a potent CSF1R inhibitor with antitumor activity and can be used to study advanced solid tumors.
  • Description
    Pimicotinib is a CSF1R inhibitor with antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    CSF1R
  • Recptor
    c-Fms
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2253123-16-7
  • Formula Weight
    420.46
  • Molecular Formula
    C22H24N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (237.83 mM; Ultrasonic )
  • SMILES
    O=C(NC=1N=C(C(OC2=CC=NC(=C2)C=3C=NN(C3)C)=CC1)C)N4C(=O)C(C)(C)CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhao BW, et al. N-(azaaryl)cyclolactam-1-carboxamide derivative, preparation method and application. World Intellectual Property Organization, WO2018214867 A1. 2018-11-29.
molnova catalog
related products
  • cFMS Receptor Inhibi...

    cFMS Receptor Inhibitor II is a?CSF1R?kinase inhibitor.

  • JNJ-28312141

    JNJ-28312141 is a potent, orally active CSF-1 receptor (CSF-1R) kinase inhibitor with IC50 of 0.69 nM.

  • CSF1R-IN-3

    CSF1R-IN-3 is an orally effective CSF-1R inhibitor with an IC50 value of 2.1 nM. CSF1R-IN-3 has anti-proliferative activity against colorectal cancer cells.